Integrated Advisors Network’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-3,744
Closed -$266K – 686
2022
Q3
$266K Buy
3,744
+1,036
+38% +$89.5K 0.02% 531
2022
Q2
$235K Buy
2,708
+72
+3% +$6.75K 0.02% 584
2022
Q1
$285K Sell
2,636
-72
-3% -$7.43K 0.02% 557
2021
Q4
$350K Sell
2,708
-152
-5% -$18.6K 0.02% 492
2021
Q3
$346K Hold
2,860
– – 0.02% 481
2021
Q2
$322K Sell
2,860
-640
-18% -$67.4K 0.02% 456
2021
Q1
$334K Sell
3,500
-260
-7% -$23.7K 0.03% 405
2020
Q4
$298K Hold
3,760
– – 0.03% 394
2020
Q3
$233K Buy
3,760
+200
+6% +$13K 0.03% 392
2020
Q2
$235K Sell
3,560
-1,900
-35% -$114K 0.03% 390
2020
Q1
$259K Buy
5,460
+280
+5% +$14K 0.05% 299
2019
Q4
$284K Buy
+5,180
New +$272K 0.04% 337

Other funds holding TECH

Integrated Advisors Network's TECH Position: Q4 2022 in Review

Integrated Advisors Network sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 3,744 shares — an estimated $266K sold.

Integrated Advisors Network first reported a position in TECH in Q4 2019 and held it in 12 quarters. The position peaked at $350K in Q4 2021. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

  • Integrated Advisors Network reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
  • Integrated Advisors Network sold 3,744 Bio-Techne shares in Q4 2022, an estimated $266K.
  • Integrated Advisors Network first reported a position in Bio-Techne in Q4 2019 and held it in 12 quarters.
  • Integrated Advisors Network's Bio-Techne position peaked at $350K in Q4 2021.
  • 545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Integrated Advisors Network's 13F filing for Q4 2022, filed 27 Jan 2023.